{
  "id": 20953475,
  "title": "'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment",
  "url": "https://urgent.news/2026/11/20/grand-slam-pancreatic-cancer-drug-shows-promise-as-first-line",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-20T20:15:46.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/othercancers/123989"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "RTE News",
        "title": "Pill for advanced pancreatic cancer shows promise",
        "url": "https://urgent.news/2026/11/20/pill-for-advanced-pancreatic-cancer-shows-promise",
        "published": "2026-11-20T18:28:05.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}